Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis

Hepatology

Volumn 8, Issue 5, 1988, Pages 1151-1157

  Schrier, Robert W ^a,b,c,d,e,f   Arroyo, Vicente ^a,b,c,d,e,f   Bernardi, Mauro ^a,b,c,d,e,f   Epstein, Murray ^a,b,c,d,e,f   Henriksen, Jens H ^a,b,c,d,e,f   Rodés, Joan ^a,b,c,d,e,f  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e HVIDOVRE HOSPITAL   (Denmark)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR RECEPTOR; RENIN;

ASCITES; BLOOD VOLUME; HEPATORENAL SYNDROME; HUMAN; LIVER CIRRHOSIS; NATRIURESIS; PRIORITY JOURNAL; REVIEW; VASODILATATION;

ANIMAL; ARTERIES; ASCITES; ATRIAL NATRIURETIC FACTOR; HEPATORENAL SYNDROME; HUMAN; KIDNEY; LIVER CIRRHOSIS; LIVER CIRRHOSIS, EXPERIMENTAL; PLASMA VOLUME; SODIUM; VASODILATION; WATER;

EID: 0023749667     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.1840080532     Document Type: Article

References (92)

1. The mechanism of ascites formation in chronic liver disease
2. The aetiology and management of ascites in patients with hepatic cirrhosis: a review
3. Role of sodium in the formation and control of ascites in patients with cirrhosis
4. The role of the kidney in Laennec's cirrhosis of the liver
5. Effective plasma volume in cirrhosis with ascites: evidence that a decreased volume does not account for renal sodium retention, a spontaneous reduction in glomerular filtration rate (GFR), and a fall in GFR during drug‐induced diuresis
6. The relationship of plasma volume portal hypertension, ascites, and renal sodium and retention in cirrhosis: the “overflow” theory of ascites formation
7. Reflex effects of hepatic baroreceptors on renal and cardiac sympathetic nerve activity
8. Sodium retention and ascites formation in dogs with experimental portal cirrhosis
9. Sodium retention in dogs with cirrhosis and ascites: efferent mechanisms
10. Renal sodium retention and ascites formation in dogs with experimental cirrhosis but without portal hypertension or increased splanchnic vascular capacity
11. Temporal relationship between urinary salt retention and altered systemic hemodynamics in dogs with experimental cirrhosis
12. Dynamics of ascites formation in rats with experimental cirrhosis
13. Hepatic hemodynamics and the renin‐angiotensin‐aldosterone system in cirrhosis
14. Hemodynamic aspects of portal hypertension
15. Increased blood flow through the portal system in cirrhotic rats
16. Systemic and splanchnic hemodynamic disturbances in conscious rats with experimental liver cirrhosis without ascites
17. Role of vasopressin in impaired water excretion in conscious rats with experimental cirrhosis
18. Cardiac failure, liver disease and nephrotic syndrome
19. Plasma volume in cirrhosis of the liver: its relation to portal hypertension, ascites and renal failure
20. Circulating atrial natriuretic peptide (ANP) and central blood volume (CBV) in cirrhosis
21. Circulation times in the splanchnic and hepatic beds in alcoholic liver disease
22. Hepatic blood flow in alcoholic liver disease measured by an indicator dilution technique
23. Quantitation of portasystemic shunting from the splenic and mesenteric beds in alcoholic liver disease
24. Hyperdynamic circulation in portal‐hypertensive rat model: a primary factor for maintenance of chronic portal hypertension
25. Changes in splanchnic blood flow in portal hypertensive rats
26. Role of humoral factors in the intestinal hyperemia associated with chronic portal hypertension
27. Hyperglucagonemia and hyperkinetic circulation after portocaval shunt in the rat
28. Substance P is markedly increased in plasma of patients with hepatic coma
29. Splanchnic hemodynamics in chronic portal hypertension
30. Aldosterone related blood volume expansions in cirrhosis before and during the early phase of ascites formation
31. Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis
32. Role of vasopressin in abnormal water excretion in cirrhotic patients
33. Temporal relationship between the impairment of free water excretion and antidiuretic hormone hypersecretion in rats with experimental cirrhosis
34. Altered renal and platelet arachidonic acid metabolism in cirrhosis
35. 9‐α‐fluorohydrocortisone induced ascites in alcoholic liver disease
36. Tubular reabsorption of sodium during acute and chronic volume expansion in man
37. Renal handling of sodium and water in early chronic liver disease. Evidence for a reduced natriuretic activity of the cirrhotic urinary extracts in rats
38. Derangement of renal water handling in liver disease
39. Renal water handling in liver disease
40. Chronobiological study of factors affecting plasma aldosterone concentration in cirrhosis
41. Chronobiological evaluation of sympathoadrenergic function in cirrhosis. Relationship with arterial pressure and heart rate
42. Renin, aldosterone and renal hemodynamics in cirrhosis with ascites
43. Plasma norepinephrine, weak neurotransmitters with renin activity during active tilting in liver cirrhosis: relationship with cardiovascular homeostasis and renal function
44. Renal function impairment induced by change in posture in patients with cirrhosis and ascites
45. Characterization of renin‐aldosterone system in decompensated cirrhosis
46. Sympathetic nervous activity and renal and systemic hemodynamics in cirrhosis: plasma norepinephrine concentration, hepatic extraction and renal release
47. Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis
48. Elevated plasma norepinephrine concentrations in decompensated cirrhosis: association with increased secretion rate, normal clearance rate and suppressibility by central blood volume expansion
49. Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosis
50. Relationship between plasma arginine‐vasopressin and renal water handling in decompensated cirrhosis
51. Circulating noradrenaline and central hemodynamics in patients with cirrhosis
52. Sympathetic nervous activity, renin‐angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion
53. Enhanced urinary excretion of cysteinil leukotrienes in patients with hepatorenal syndrome (Abstract)
54. Prostaglandins: modulators of renal function and pressor resistance in chronic liver disease
55. Urinary excretion of 6‐ketoprostaglandin F1, thromboxane B2 and prostaglandin E2 in cirrhosis with ascites. Relationship to functional renal failure (hepatorenal syndrome)
56. Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis
57. Effect of angiotensin II blockade on systemic and hepatic hemodynamics and on the renin‐angiotensin‐aldosterone system in cirrhosis with ascites
58. Sympathetic tone modulates portal venous pressure in alcoholic cirrhosis
59. Acute effects of captopril on systemic and renal hemodynamics and on renal function in cirrhotic patients with ascites
60. Randomized comparative study on efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin‐aldosterone system
61. Importance of plasma aldosterone on natriuretic effect of spironolactone in patients with liver cirrhosis and ascites
62. Specific and non‐specific inhibition of mineralcorticoid activity
63. Plasma angiotensin II concentration regulates vascular but not adrenal responsiveness to restriction of sodium intake in normal man
64. Sodium intake alters the effects of norepinephrine on blood pressure
65. Effect of indomethacin and prostaglandin A on renal function and plasma renin activity in alcoholic liver disease
66. Renal prostaglandins and the control of renal function in liver disease
67. Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti‐inflammatory drugs in cirrhosis with ascites
68. Renal kallikrein excretion in cirrhotics with ascites: relationship to renal hemodynamics
69. Decreased plasma arterial natriuretic peptides in cirrhotic ascitic patients (Abstract)
70. Atrial natriuretic peptide in hepatic cirrhosis: relation to stage of disease, sympathoadrenal system and renin‐aldosterone axis
71. Plasma levels of immunoreactive atrial natriuretic factor in healthy subjects and in patients with edema
72. Plasma atrial natriuretic factor in patients with cirrhosis
73. Plasma levels of atrial natriuretic peptide in cirrhotic patients
74. Atrial natriuretic protein (ANP) in the hepatorenal syndrome (HRS) (Abstract)
75. Atrial natriuretic factor in cirrhosis with ascites: plasma levels, cardiac release and splanchnic extraction
76. Relationship of increased plasma atrial natriuretic factor and renal sodium and handling during immersion‐induced central hypervolemia in normal humans
77. The pressure‐volume responses of human forearm veins during epinephrine and norepinephrine infusions
78. Peripheral venous and arteriolar responses to infusions of angiotensin in normal and hypertensive subjects
79. Interrelationship between cardiac output and vascular resistance as determinants of effective arterial blood volume in cirrhotic patients
80. Sodium excretion in advanced cirrhosis: effects of expansion of central blood volume and suppression of plasma aldosterone
81. Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: evidence for increased vasoconstrictor and decreased vasodilator factors
82. Therapeutic trial on thromboxane synthesis inhibition in the hepatorenal syndrome
83. Paracentesis vs paracentesis plus iv albumin in the treatment of ascites. Preliminary results of a comparative study (Abstract)
84. Effects of therapeutic paracentesis on systemic and hepatic hemodynamics and on renal and hormonal function
85. Effects of arteriovenous fluids on renal hemodynamics and electrolyte excretion
86. Temporal relationship between hyperaldosteronism, sodium retention and ascites formation in rats with experimental cirrhosis. Effect of spironolactone
87. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhosis with ascites
88. Systemic and renal hemodynamics in oliguric hepatic failure: effect of volume expansion
89. Plasma catecholamine level and portal venous pressures as guides to prognosis in patients with cirrhosis
90. Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites
91. Valeur prognostique du système reneine‐angiotensine dans la réponse à la restriction sodée et le pronostic de l'ascite cirrhotique d'origine alcoölique